Turning Point Therapeutics, Inc. Variable Lease, Cost
Turning Point Therapeutics, Inc. reported Variable Lease, Cost of $400.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2022-08-08
- Turning Point Therapeutics, Inc. variable lease, cost for the quarter ending 2022-06-30 was $400.00K, a 33.33% increase year-over-year.
- Turning Point Therapeutics, Inc. variable lease, cost for the quarter ending 2022-03-31 was $400.00K, a 33.33% increase year-over-year.
- Turning Point Therapeutics, Inc. variable lease, cost for the quarter ending 2021-06-30 was $300.00K.
- Turning Point Therapeutics, Inc. variable lease, cost for the quarter ending 2021-03-31 was $300.00K.
- Turning Point Therapeutics, Inc. variable lease, cost for fiscal 2021 was $1.40M, a 16.67% increase from fiscal 2020.
- Turning Point Therapeutics, Inc. variable lease, cost for fiscal 2020 was $1.20M, a 71.43% increase from fiscal 2019.
- Turning Point Therapeutics, Inc. variable lease, cost for fiscal 2019 was $700.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 12 month |
|---|---|---|---|
| 2022-06-30 | $400.00K 10-Q · filed 2022-08-08 | $800.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $400.00K 10-Q · filed 2022-05-10 | ||
| 2021-12-31 | $1.40M 10-K · filed 2022-02-28 | ||
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-08 | $600.00K 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $300.00K 10-Q · filed 2022-05-10 | ||
| 2020-12-31 | $1.20M 10-K · filed 2022-02-28 | ||
| 2019-12-31 | $700.00K 10-K · filed 2022-02-28 |